Search

Your search keyword '"P, Cavalla"' showing total 324 results

Search Constraints

Start Over You searched for: Author "P, Cavalla" Remove constraint Author: "P, Cavalla"
324 results on '"P, Cavalla"'

Search Results

1. Exploring the Impact of Environmental Pollutants on Multiple Sclerosis Progression

3. Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry

4. Signs and symptoms of COVID‐19 in patients with multiple sclerosis

5. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose

6. Expressing Emotions, Discussing Controversial Issues: A Pilot Study Focused on Veganism

7. Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)

8. Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study

9. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis

10. Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

11. A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibility

12. Sex effects across the lifespan in women with multiple sclerosis

13. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

15. Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study

18. PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study

19. The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19

21. Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study

23. Correction to: A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibility

24. Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population

25. Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study

26. Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

27. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

28. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

29. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

30. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

31. Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

34. A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study

43. Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis

46. Abstracts

50. Performance of the 2017 AAP/EFP case definition compared with the CDC/AAP definition in population-based studies.

Catalog

Books, media, physical & digital resources